Hamit Ali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hamit Ali has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Ali Osman Saatci
Department of Ophthalmology, Dokuz Eylul University, Izmir, Türkiye
2 shared publications - Nargis Ahmadova
Department of Ophthalmology, Dokuz Eylul University School of Medicine
2 shared publications - Ozlem Ural Fatihoglu
Dokuz Eylül University Faculty of Medicine, Department of Ophthalmology, İzmir, Türkiye
2 shared publications - Ahmet Gurakar
Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
1 shared publication - Ahmet Okay Caglayan
Department of Medical Genetics, Dokuz Eylul University School of Medicine, Izmir, Turkey
1 shared publication Ali Devebacak
Ege University, Faculty of Medicine
1 shared publication
Latest Publications
- Open Access
- 6 August 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1)
Role of surgeon seniority in predicting surgically induced astigmatism after phacoemulsification surgery: a machine learning study
Purpose: To evaluate whether surgeon seniority influences postoperative astigmatic change after phacoemulsification cataract surgery and to assess the performance of machine-learning models in predicting postoperative astigmatic outcomes using preoperative clinical data. Methods: This study included 169 eyes of 169 patients who underwent phacoemulsification cataract surgery. Surgeons were categorized as residents ( n = 101) or specialists ( n = 68). Astigmatism was quantified using both classical magnitude-based analysis and vector decomposition. Potential determinants of postoperative astigmatic change were evaluated using multivariable regression analyses. Machine-learning models, including Gradient Boosting, K-Nearest Neighbors, Decision Tree, and Support Vector Machine models, were used to predict classical and vector astigmatism outcomes. Model performance was assessed using mean absolute error, root mean square error, and the coefficient of determination. Results: Of the 169 eyes, 101 were operated on by residents and 68 by specialists. Postoperative astigmatic change did not differ significantly between resident- and specialist-performed procedures in either classical or vector analyses. Within the resident group, increasing surgical seniority was not associated with postoperative astigmatic change. In multivariable analysis, preoperative cylindrical error was the only significant predictor in the vector model, whereas no significant predictor was identified in the classical model. Overall, machine-learning models demonstrated limited predictive performance, with only modest utility for classical astigmatism and poor explanatory performance for vector outcomes. Conclusion: Surgeon seniority was not a significant determinant of surgically induced astigmatism after phacoemulsification cataract surgery. Machine-learning models based on preoperative clinical data provided only limited predictive value, particularly for vector astigmatism outcomes. Incorporating intraoperative variables may improve future predictive performance.
- 6 August 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1)
Open AccessRole of surgeon seniority in predicting surgically induced astigmatism after phacoemulsification surgery: a machine learning study
Purpose: To evaluate whether surgeon seniority influences postoperative astigmatic change after phacoemulsification cataract surgery and to assess the performance of machine-learning models in predicting postoperative astigmatic outcomes using preoperative clinical data. Methods: This study included 169 eyes of 169 patients who underwent phacoemulsification cataract surgery. Surgeons were categorized as residents ( n = 101) or specialists ( n = 68). Astigmatism was quantified using both classical magnitude-based analysis and vector decomposition. Potential determinants of postoperative astigmatic change were evaluated using multivariable regression analyses. Machine-learning models, including Gradient Boosting, K-Nearest Neighbors, Decision Tree, and Support Vector Machine models, were used to predict classical and vector astigmatism outcomes. Model performance was assessed using mean absolute error, root mean square error, and the coefficient of determination. Results: Of the 169 eyes, 101 were operated on by residents and 68 by specialists. Postoperative astigmatic change did not differ significantly between resident- and specialist-performed procedures in either classical or vector analyses. Within the resident group, increasing surgical seniority was not associated with postoperative astigmatic change. In multivariable analysis, preoperative cylindrical error was the only significant predictor in the vector model, whereas no significant predictor was identified in the classical model. Overall, machine-learning models demonstrated limited predictive performance, with only modest utility for classical astigmatism and poor explanatory performance for vector outcomes. Conclusion: Surgeon seniority was not a significant determinant of surgically induced astigmatism after phacoemulsification cataract surgery. Machine-learning models based on preoperative clinical data provided only limited predictive value, particularly for vector astigmatism outcomes. Incorporating intraoperative variables may improve future predictive performance.
- 13 July 2026
- Published by Taylor & Francis in Current Eye Research
- Vol. 51 (11) , 1261-1263
Letter to the Editor: Retinal and Choroidal Changes in Neurofibromatosis Type 1 in Relation to Diagnostic Criteria and Disease Severity
- 13 July 2026
- Published by Taylor & Francis in Current Eye Research
- Vol. 51 (11) , 1261-1263
Letter to the Editor: Retinal and Choroidal Changes in Neurofibromatosis Type 1 in Relation to Diagnostic Criteria and Disease Severity
- Open Access
- 9 July 2026
- Published by Springer Nature in Research Square
Topical Losartan for the Treatment of Herpetic Corneal Scars
Objectives To evaluate the clinical efficacy of topical losartan in patients with corneal scarring secondary to herpes simplex keratitis (HSK). Methods In this retrospective multicenter study, patients with corneal haze following HSK episodes and inadequate visual improvement with standard treatment received topical losartan 0.8 mg/mL in balanced salt solution four times daily. Examinations were performed at baseline and at 1, 3, and 6 months. Outcome measurements included visual acuity, corneal opacity area measured with ImageJ, and corneal densitometry obtained by corneal tomography. Results Fifty-seven eyes of 57 patients were included. Mean age was 54.23 ± 18.77 years, and mean disease duration was 10.60 ± 10.16 years. Mean best-corrected visual acuity improved significantly from 0.60 ± 0.70 logMAR at baseline to 0.52 ± 0.63 at 1 month, 0.45 ± 0.55 at 3 months, and 0.40 ± 0.57 at 6 months (all p ≤ 0.001). At 6 months, 30 patients (65%) showed improvement in visual acuity, whereas 14 (30%) remained stable and 2 (4%) worsened. Mean corneal opacity area decreased significantly from 24.44 ± 20.64 mm² to 22.36 ± 19.93 mm² (p < 0.001). Corneal densitometry analysis revealed significant reductions in anterior layer density (40.91 ± 15.56 to 36.86 ± 13.65 GSU, p < 0.001), central layer density (32.79 ± 14.30 to 29.21 ± 12.85 GSU, p < 0.05), and total corneal density (32.55 ± 13.22 to 29.79 ± 11.75 GSU, p < 0.05) at 6 months. In contrast, the reduction in posterior density was not statistically significant. Conclusions Topical losartan emerges as a promising adjunctive antifibrotic therapy for post-HSK corneal scarring, demonstrating improvements in visual acuity, opacity area, and corneal densitometry over 6 months. Prospective studies are needed to determine the optimal diagnosis and timing for this treatment.
- 9 July 2026
- Published by Springer Nature in Research Square
Open AccessTopical Losartan for the Treatment of Herpetic Corneal Scars
Objectives To evaluate the clinical efficacy of topical losartan in patients with corneal scarring secondary to herpes simplex keratitis (HSK). Methods In this retrospective multicenter study, patients with corneal haze following HSK episodes and inadequate visual improvement with standard treatment received topical losartan 0.8 mg/mL in balanced salt solution four times daily. Examinations were performed at baseline and at 1, 3, and 6 months. Outcome measurements included visual acuity, corneal opacity area measured with ImageJ, and corneal densitometry obtained by corneal tomography. Results Fifty-seven eyes of 57 patients were included. Mean age was 54.23 ± 18.77 years, and mean disease duration was 10.60 ± 10.16 years. Mean best-corrected visual acuity improved significantly from 0.60 ± 0.70 logMAR at baseline to 0.52 ± 0.63 at 1 month, 0.45 ± 0.55 at 3 months, and 0.40 ± 0.57 at 6 months (all p ≤ 0.001). At 6 months, 30 patients (65%) showed improvement in visual acuity, whereas 14 (30%) remained stable and 2 (4%) worsened. Mean corneal opacity area decreased significantly from 24.44 ± 20.64 mm² to 22.36 ± 19.93 mm² (p < 0.001). Corneal densitometry analysis revealed significant reductions in anterior layer density (40.91 ± 15.56 to 36.86 ± 13.65 GSU, p < 0.001), central layer density (32.79 ± 14.30 to 29.21 ± 12.85 GSU, p < 0.05), and total corneal density (32.55 ± 13.22 to 29.79 ± 11.75 GSU, p < 0.05) at 6 months. In contrast, the reduction in posterior density was not statistically significant. Conclusions Topical losartan emerges as a promising adjunctive antifibrotic therapy for post-HSK corneal scarring, demonstrating improvements in visual acuity, opacity area, and corneal densitometry over 6 months. Prospective studies are needed to determine the optimal diagnosis and timing for this treatment.
- Open Access
- 17 June 2026
- Published by Elsevier in AJO International
- Vol. 3 (3)
Demographics and distribution of intravitreal injections in the pediatric age group between 2008 and 2025
- 17 June 2026
- Published by Elsevier in AJO International
- Vol. 3 (3)
Open AccessDemographics and distribution of intravitreal injections in the pediatric age group between 2008 and 2025
- Open Access
- 12 January 2026
- Published by SMC Media in European Journal of Case Reports in Internal Medicine
- Vol. 13 (2)
Unilateral Yasunari nodule-like appearance in a patient without neurofibromatosis type 1
Introduction: Yasunari nodules are choroidal lesions characterized by bright, poorly demarcated multiple lesions detected through near-infrared reflectance imaging and are considered diagnostic for neurofibromatosis type 1 (NF1). We report a case of unilateral Yasunari-like nodules in a patient without clinical or genetic evidence of NF1. Case description: A 53-year-old male presented with a 7-day history of floaters in both eyes. Best-corrected visual acuity was 20/20 in the right eye and 20/25 in the left eye. Slit-lamp examination revealed bilateral multiple iris nevi. Both fundi appeared normal on colour photography. The right infrared image demonstrated multiple bright, relatively well-defined areas suggesting Yasunari nodules, whereas the left infrared image was normal. Green and blue autofluorescent images were unremarkable bilaterally. Spectral domain optical coherence tomography revealed poorly demarcated hyperreflective choroidal nodule-like changes in the right eye only. Physical examination revealed no signs of NF1. Next-generation deoxyribonucleic acid sequencing of blood and skin specimens was negative for NF1. Discussion: This is the second reported case of unilateral Yasunari-like nodules in a patient without NF1. Despite extensive clinical and genetic evaluation, including testing for somatic mosaicism, all results were negative for NF1. The lesions were considered benign incidental findings and monitored conservatively. Conclusion: Although infrequent, lesions resembling Yasunari nodules may be observed in patients without NF1. Clinicians should be aware of this possibility when encountering similar imaging findings.
- 12 January 2026
- Published by SMC Media in European Journal of Case Reports in Internal Medicine
- Vol. 13 (2)
Open AccessUnilateral Yasunari nodule-like appearance in a patient without neurofibromatosis type 1
Introduction: Yasunari nodules are choroidal lesions characterized by bright, poorly demarcated multiple lesions detected through near-infrared reflectance imaging and are considered diagnostic for neurofibromatosis type 1 (NF1). We report a case of unilateral Yasunari-like nodules in a patient without clinical or genetic evidence of NF1. Case description: A 53-year-old male presented with a 7-day history of floaters in both eyes. Best-corrected visual acuity was 20/20 in the right eye and 20/25 in the left eye. Slit-lamp examination revealed bilateral multiple iris nevi. Both fundi appeared normal on colour photography. The right infrared image demonstrated multiple bright, relatively well-defined areas suggesting Yasunari nodules, whereas the left infrared image was normal. Green and blue autofluorescent images were unremarkable bilaterally. Spectral domain optical coherence tomography revealed poorly demarcated hyperreflective choroidal nodule-like changes in the right eye only. Physical examination revealed no signs of NF1. Next-generation deoxyribonucleic acid sequencing of blood and skin specimens was negative for NF1. Discussion: This is the second reported case of unilateral Yasunari-like nodules in a patient without NF1. Despite extensive clinical and genetic evaluation, including testing for somatic mosaicism, all results were negative for NF1. The lesions were considered benign incidental findings and monitored conservatively. Conclusion: Although infrequent, lesions resembling Yasunari nodules may be observed in patients without NF1. Clinicians should be aware of this possibility when encountering similar imaging findings.
- Open Access
- 1 January 2024
- Published by Kare Publishing in Hepatology Forum
- Vol. 5 (4) , 207-210
Current status of simultaneous liver-kidney transplantation
Simultaneous liver-kidney transplantation (SLK) is a feasible option for patients with end-stage liver disease and concomitant renal dysfunction or end-stage renal disease. SLK has gained significant attention primarily due to multiple alterations in the allocation criteria over the past two decades. This review aims to summarize the most recent updates and outcomes of the SLK allocation policy, comparing SLK outcomes with those of liver transplantation alone and exploring the implications of donation after cardiac death in SLK procedures.
- 1 January 2024
- Published by Kare Publishing in Hepatology Forum
- Vol. 5 (4) , 207-210
Open AccessCurrent status of simultaneous liver-kidney transplantation
Simultaneous liver-kidney transplantation (SLK) is a feasible option for patients with end-stage liver disease and concomitant renal dysfunction or end-stage renal disease. SLK has gained significant attention primarily due to multiple alterations in the allocation criteria over the past two decades. This review aims to summarize the most recent updates and outcomes of the SLK allocation policy, comparing SLK outcomes with those of liver transplantation alone and exploring the implications of donation after cardiac death in SLK procedures.